Collins N, Beaty S, Wallace E, Li Y, Sanborn M, Yang Y
Vaccines (Basel). 2023; 11(7).
PMID: 37514960
PMC: 10385111.
DOI: 10.3390/vaccines11071144.
Beaty S, Collins N, Karasavvas N, Kuschner R, Hang J, Adhikari A
Vaccines (Basel). 2023; 11(6).
PMID: 37376480
PMC: 10301169.
DOI: 10.3390/vaccines11061091.
Li Y, Wang D, Zhang J, Huang P, Du H, Xu J
Front Cell Infect Microbiol. 2021; 11:684606.
PMID: 34490137
PMC: 8417316.
DOI: 10.3389/fcimb.2021.684606.
Chen S, Tian X
J Thorac Dis. 2018; 10(Suppl 19):S2280-S2294.
PMID: 30116607
PMC: 6072920.
DOI: 10.21037/jtd.2018.03.168.
Zhao S, Wan C, Ke C, Seto J, Dehghan S, Zou L
Sci Rep. 2014; 4:7365.
PMID: 25482188
PMC: 4258649.
DOI: 10.1038/srep07365.
Computational analysis of four human adenovirus type 4 genomes reveals molecular evolution through two interspecies recombination events.
Dehghan S, Seto J, Liu E, Walsh M, Dyer D, Chodosh J
Virology. 2013; 443(2):197-207.
PMID: 23763770
PMC: 3779658.
DOI: 10.1016/j.virol.2013.05.014.
Replicating adenovirus vector prime/protein boost strategies for HIV vaccine development.
Patterson L, Robert-Guroff M
Expert Opin Biol Ther. 2008; 8(9):1347-63.
PMID: 18694354
PMC: 2538611.
DOI: 10.1517/14712598.8.9.1347.
Replication-attenuated Human Adenoviral Type 4 vectors elicit capsid dependent enhanced innate immune responses that are partially dependent upon interactions with the complement system.
Hartman Z, Appledorn D, Serra D, Glass O, Mendelson T, Clay T
Virology. 2008; 374(2):453-67.
PMID: 18280530
PMC: 2720025.
DOI: 10.1016/j.virol.2008.01.017.
Viral vector-based gene transfer for treatment of chronic pain.
Hao S, Mata M, Fink D
Int Anesthesiol Clin. 2007; 45(2):59-71.
PMID: 17426508
PMC: 2769565.
DOI: 10.1097/AIA.0b013e318034199c.
Development and assessment of human adenovirus type 11 as a gene transfer vector.
Stone D, Ni S, Li Z, Gaggar A, DiPaolo N, Feng Q
J Virol. 2005; 79(8):5090-104.
PMID: 15795294
PMC: 1069572.
DOI: 10.1128/JVI.79.8.5090-5104.2005.
Genomic and bioinformatics analysis of HAdV-4, a human adenovirus causing acute respiratory disease: implications for gene therapy and vaccine vector development.
Purkayastha A, Ditty S, Su J, McGraw J, Hadfield T, Tibbetts C
J Virol. 2005; 79(4):2559-72.
PMID: 15681456
PMC: 546560.
DOI: 10.1128/JVI.79.4.2559-2572.2005.
Molecular analysis of adenovirus isolates from vaccinated and unvaccinated young adults.
Blasiole D, Metzgar D, Daum L, Ryan M, Wu J, Wills C
J Clin Microbiol. 2004; 42(4):1686-93.
PMID: 15071026
PMC: 387592.
DOI: 10.1128/JCM.42.4.1686-1693.2004.
Diversity of airway epithelial cell targets for in vivo recombinant adenovirus-mediated gene transfer.
Mastrangeli A, Danel C, Rosenfeld M, Perricaudet M, Pavirani A, Lecocq J
J Clin Invest. 1993; 91(1):225-34.
PMID: 8423221
PMC: 330018.
DOI: 10.1172/JCI116175.
Stable delivery of physiologic levels of recombinant erythropoietin to the systemic circulation by intramuscular injection of replication-defective adenovirus.
Tripathy S, GOLDWASSER E, Lu M, Barr E, Leiden J
Proc Natl Acad Sci U S A. 1994; 91(24):11557-61.
PMID: 7972101
PMC: 45270.
DOI: 10.1073/pnas.91.24.11557.
Testing the safety and effectiveness of oral administration of a live influenza vaccine.
Aleksandrova G, SMORODINTSEV A, Beljaeva N, Vasilev B, GEFT R, Panteleev V
Bull World Health Organ. 1970; 42(3):429-36.
PMID: 5310592
PMC: 2427545.
Enteric immunization with live adenovirus type 21 vaccine. I. Tests for safety, infectivity, immunogenicity, and potency in volunteers.
DUDDING B, Bartelloni P, Scott R, Top Jr F, RUSSELL P, Buescher E
Infect Immun. 1972; 5(3):295-9.
PMID: 4564559
PMC: 422364.
DOI: 10.1128/iai.5.3.295-299.1972.
Pathology of exfoliated oropharyngeal epithelial cells infected with wild-type adenovirus.
McCormick D, Galapon Q, BERLING C
Appl Microbiol. 1972; 24(3):389-97.
PMID: 4342841
PMC: 376529.
DOI: 10.1128/am.24.3.389-397.1972.
Vaccination with live type 4 adenovirus: evaluation of antibody response and protective efficacy.
van der Veen J, Abarbanel M, OEI K
J Hyg (Lond). 1968; 66(4):499-511.
PMID: 4303951
PMC: 2130674.
DOI: 10.1017/s0022172400028242.
Homotypic and heterotypic antibody response in infants to adenovirus vaccine.
van der Veen J, VAN ZAANE D, Sprangers M, HEYEN C
Arch Gesamte Virusforsch. 1967; 21(3):320-33.
PMID: 4300740
DOI: 10.1007/BF01241733.
The degree of genetic variability among adenovirus type 4 strains isolated from man and chimpanzee.
Li Q, Wadell G
Arch Virol. 1988; 101(1-2):65-77.
PMID: 2843149
DOI: 10.1007/BF01314652.